purple-menu-iconbanner-menu-icon-open

BIS

UltraShort Nasdaq Biotechnology

Investment Objective

ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

Daily Return during Q2 2022
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund + Index 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIS Market Price 20.24% 15.04% 55.53% 44.44% 37.72% -26.22% -22.76% -33.49% -34.41% 04/07/2010
BIS NAV 20.24% 14.92% 55.60% 44.18% 37.49% -26.24% -22.77% -33.51% -34.41% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker BIS
  • Intraday Ticker BIS.IV
  • CUSIP 74347G838
  • Inception Date 4/7/10
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.55%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 5/20/2022
  • NAV $28.90
  • NAV Change $-0.47 down caret
  • Market Price $28.84
  • Market Price Change $-0.58 down caret
  • Trading Volume (M) 32,172
  • 30-Day Median Bid Ask Spread 0.29%
  • View Premium / Discount
Snapshot
  • Ticker BIS
  • Intraday Ticker BIS.IV
  • CUSIP 74347G838
  • Inception Date 4/7/10
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.55%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 5/20/2022
  • NAV $28.90
  • NAV Change $-0.47 down caret
  • Market Price $28.84
  • Market Price Change $-0.58 down caret
  • Trading Volume (M) 32,172
  • 30-Day Median Bid Ask Spread 0.29%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/22.

Exposures

Index as of 3/31/2022

Holdings

as of 5/20/2022

Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts
-- -- NET OTHER ASSETS (LIABILITIES) -- $8,555,295.66 8,555,296
-8.13% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC -695,315 -- -168
-19.85% -- NASDAQ BIO INDEX SWAP BNP -1,698,389 -- -460
-43.15% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE -3,691,792 -- -892
-43.97% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA -3,762,151 -- -909
-44.65% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG -3,820,094 -- -923
-55.63% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA -4,759,597 -- -1,150

Index

as of 3/31/2022

  • Total Number of Companies370
  • Price/Book Ratio5.716
  • Dividend Yield ( % )0.64
  • Avg. Index Market Capitalization$4.10 billion
About the Index

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series Research & Insights

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This short ProShares ETF seeks a return that is -2x the return of its underlying benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, holding periods of greater than one day can result in returns that are significantly different than the target return, and ProShares' returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. Investors should monitor their holdings as frequently as daily. Investors should consult the prospectus for further details on the calculation of the returns and the risks associated with investing in this product.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Short ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Short ProShares ETFs should lose money when their benchmarks rise. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

Investments in the debt of sub-sovereigns (including agency-issued securities) and quasi-sovereigns (i.e. corporations that have significant government ownership) may or may not be issued by or guaranteed as to principal and interest by a governmental authority.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

"Deutsche Bank" and "DBIQ Short Duration Emerging Market Bond IndexSM" are service marks of Deutsche Bank AG and have been licensed for use for certain purposes by ProShares. ProShares have not been passed on by Deutsche Bank AG as to their legality or suitability. ProShares based on the DBIQ Short Duration Emerging Market Bond Index are not sponsored, endorsed, sold, or promoted by Deutsche Bank AG, and Deutsche Bank makes no representation, express or implied, regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares ETFs (ProShares Trust and ProShares Trust II) are distributed by SEI Investments Distribution Co., which is not affiliated with the funds' advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.